Vivos Therapeutics (VVOS) Retained Earnings (2019 - 2026)
Vivos Therapeutics (VVOS) reported Retained Earnings of -$133.0 million for Q1 2026, down 23.03% year-over-year from -$172.8 million in Q1 2025, and down 6.1% on a QoQ basis from -$125.4 million in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Retained Earnings data on file, last reported at -$133.0 million in Q1 2026.
- Quarterly Retained Earnings fell 23.03% year-over-year to -$133.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$133.0 million (down 23.03% YoY) and the FY2025 annual result came in at -$125.4 million, down 20.32% from the prior year.
- Retained Earnings retreated to -$133.0 million in Q1 2026 per VVOS's latest filing, from -$125.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$61.0 million in Q1 2022 and bottomed at -$133.0 million in Q1 2026.
- The 5-year median for Retained Earnings is -$96.8 million (2024), against an average of -$95.9 million.
- The widest annual swing landed in 2022, when Retained Earnings sank 58.84%; it then retreated 11.67% in 2025.
- Tracing VVOS's Retained Earnings over 5 years: stood at -$79.5 million in 2022, then retreated by 17.09% to -$93.1 million in 2023, then slipped by 11.97% to -$104.2 million in 2024, then slipped by 20.32% to -$125.4 million in 2025, then dropped by 6.1% to -$133.0 million in 2026.
- Per Business Quant, the three latest VVOS Retained Earnings figures stand at -$133.0 million (Q1 2026), -$125.4 million (Q4 2025), and -$118.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.00 Mn |
| Dec 31, 2025 | -125.36 Mn |
| Sep 30, 2025 | -118.46 Mn |
| Jun 30, 2025 | -113.06 Mn |
| Mar 31, 2025 | -108.10 Mn |
| Dec 31, 2024 | -104.19 Mn |
| Sep 30, 2024 | -101.36 Mn |
| Jun 30, 2024 | -98.74 Mn |
| Mar 31, 2024 | -96.81 Mn |
| Dec 31, 2023 | -93.05 Mn |
| Sep 30, 2023 | -88.79 Mn |
| Jun 30, 2023 | -86.70 Mn |
| Mar 31, 2023 | -81.20 Mn |
| Dec 31, 2022 | -79.47 Mn |
| Sep 30, 2022 | -73.40 Mn |
| Jun 30, 2022 | -67.95 Mn |
| Mar 31, 2022 | -61.00 Mn |
| Dec 31, 2021 | -55.62 Mn |
| Sep 30, 2021 | -48.23 Mn |
| Jun 30, 2021 | -42.78 Mn |
| Mar 31, 2021 | -38.73 Mn |
| Dec 31, 2020 | -35.34 Mn |
| Dec 31, 2019 | -23.28 Mn |